Infinity Clinical Research

06/24/2024

Thinking about participating in a clinical trial? Click the link below to learn more about our current studies.

https://connect.studycatalyst.com/ #/listings/987519b5-1b2a-42df-a413-cffac398246b/iframe

05/07/2024

The PROGRESS study is being done to find out the efficacy of an investigational drug called LX9211 in reducing pain related to diabetic peripheral neuropathy.

LX9211 is a new type of investigational drug called an AP2-associated protein kinase 1 inhibitor (AAK1 inhibitor). It is believed that inhibiting AAK1 may help reduce pain caused by diabetic neuropathy.

You may qualify to participate if you:
• Are 18 years of age or older
• Have type 1 or type 2 diabetes
• Have an A1C less than or equal to 11%
• Have ongoing diabetic peripheral neuropathy with moderate to severe pain

Your medical history and other criteria will be checked to see if you can take part in the study.

The study lasts about 16 weeks. Qualified participants will not have to pay for the study drug, study visits, or for the procedures or tests that are needed as part of this study. Additionally, you may be compensated for your time and reimbursed for approved, study-related travel.

For info please contact:
Becky Nembhard, BS, CRC
Lead Clinical Research Coordinator
rnembhard@infinityclinicalresearch.com
954-366-0277, ext 124

Working to Advance Progressive Treatments for Patients Through Clinical Trials

04/03/2024

Are you caring for someone with, or who may have, Alzheimer’s disease? Are they showing signs of restlessness, aggression, or irritability?

Researchers who are working on the ADVANCE-2 study are examining if an investigational medication may work to help these symptoms. At this time, there is no approved treatment for restlessness, aggression, or irritability associated with Alzheimer’s disease.

Who can participate in the study?

To be considered for this study, your family member must:
- Be between the ages of 65 and 90 years old
- Have been diagnosed with Alzheimer’s disease, or is showing symptoms of Alzheimer’s
- Be currently showing signs of restlessness, aggression, or irritability

The caregiver must:
- Be a family member who has been caring for the person on a regular basis
- Be willing to attend study visits
- Complete documents on behalf of your family member

*please note other criteria may apply

For more info please contact:
Muskaan Ochani, BS, CRC – 954.366.0277 ext 122
Lucy Vargas, MA, CRC – 954.366.0277 ext 124